Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Minsat

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Brachytherapy|September 14, 2019
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancersLeonel Varela Cagetti, Christophe Zemmour, Naji Salem, et al.
Biomedicines|September 23, 2022
Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain MetastasesJudith Porte, Caroline Saint-Martin, Thomas Frederic-Moreau, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study)Cécile Ortholan, Michel Resbeut, Jean-Michel Hannoun-Levi, et al.
BMC Surgery|November 17, 2016
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survivalEric Lambaudie, Gilles Houvenaeghel, Amira Ziouèche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trialVéronique Vendrely, Philippe Ronchin, Mathieu Minsat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell CarcinomaLuc Cabel, Emmanuelle Jeannot, Ivan Bieche, et al.
BMC Cancer|November 25, 2014
Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohortsAmira Ziouèche-Mottet, Gilles Houvenaeghel, Jean Marc Classe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2025
Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASEClara Naessens, Cécile Evin, Karine Le-Malicot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASEVéronique Vendrely, Claire Lemanski, Pascal Pommier, et al.
Nature Communications|June 22, 2023
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trialManuel Rodrigues, Giulia Vanoni, Pierre Loap, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Brachytherapy|September 14, 2019
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancersLeonel Varela Cagetti, Christophe Zemmour, Naji Salem, et al.
Biomedicines|September 23, 2022
Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain MetastasesJudith Porte, Caroline Saint-Martin, Thomas Frederic-Moreau, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study)Cécile Ortholan, Michel Resbeut, Jean-Michel Hannoun-Levi, et al.
BMC Surgery|November 17, 2016
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survivalEric Lambaudie, Gilles Houvenaeghel, Amira Ziouèche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trialVéronique Vendrely, Philippe Ronchin, Mathieu Minsat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell CarcinomaLuc Cabel, Emmanuelle Jeannot, Ivan Bieche, et al.
BMC Cancer|November 25, 2014
Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohortsAmira Ziouèche-Mottet, Gilles Houvenaeghel, Jean Marc Classe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2025
Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASEClara Naessens, Cécile Evin, Karine Le-Malicot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASEVéronique Vendrely, Claire Lemanski, Pascal Pommier, et al.
Nature Communications|June 22, 2023
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trialManuel Rodrigues, Giulia Vanoni, Pierre Loap, et al.
Pageof 3